In Silico Prediction of Isoliquiritigenin and Oxyresveratrol Compounds to BCL-2 dan VEGF-2 Receptors

Roihatul Mutiah, Muhammad Fawaz Hariz, Yen Yen Ari Indrawijaya, Burhan Ma'arif


Isoliquiritigenin and oxyresveratrol are compounds that have been reported to have anticancer activities. This study aimed to predict cytotoxic activity, toxicity and physicochemical properties of the compounds isoliquiritigenin and oxyresveratrol. Prediction of physicochemical properties referred to Lipinski rules of five using the pkCSM online tool. Prediction of compounds toxicity using Protox II online tool while ligand interaction with receptors using Molegro Virtual Docker (MVD). Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) (PDB: 2RL5) and B Cell Lymphoma BCL-2 (PDB: 4AQ3) were used as target cancer receptor proteins. In silico predictive results showed that oxyresveratrol and isoliquiritigenin complied with Lipinski rules of five, predictive values of LD50 between 500-2000 mg/kg respectively 1560 mg/kg and 1048 mg/kg. The docking result was in the form of bound energy described by Rerank Score (RS). A compound having a small RS value was predicted to have greater activity. RS of oxyresveratrol on 2RL5: -73.0413 and 4AQ3: -87.9985, while isoliquiritigenin on 2RL5: -68.0282 and 4AQ3: -78.5041. The cytotoxic activity of oxyresveratrol was also shown by hydrogen bonds in active amino acids (2RL5: Cys 919 in 4AQ3: Tyr 67). From docking results of both compounds, oxyreveratrol had greater activity than isoliquiritigenin to both target cancer receptor proteins and complied Lipinski rules of five and have a low toxicity.
Keywords: cytotoxicity, toxicity, isoliquiritigenin, oxyresveratrol, in silico.

Full Text:



Ayeka, P.A., Bian, Y., Mwitari, P.G., Chu, X., Zhang, Y., Uzayisenga, R., and Otachi, E.O., 2016, Immunomodulatory and anticancer potential of Gan cao (Glycyrrhiza uralensis Fisch.) polysaccharides by CT-26 colon carcinoma cell growth inhibition and cytokine IL-7 upregulation in vitro, BMC complementary and alternative medicine, 16, 206. CrossRef

Baek, Y.Y, Lee, D.K., Kim, J., Kim, J.H., Park, W., Kim, T., Han, S., Jeoung, D., You, J.C., Lee, H., Won, M.H., Ha, K.S., Kwon, Y.G., and Kim, Y.M., 2017, Arg-Leu-Tyr-Glu Tetrapeptide Inhibits Tumor Progression by Suppressing Angiogenesis and Vascular Permeability Via Vegf Receptor-2 Antagonism, Oncotarget, 8(7), 11763-11777. CrossRef

Cao, Y., Wang, Y., Ji, C., and Ye, J., 2004, Determination of Liquiritigenin and Isoliquiritigenin In Glycyrrhiza Uralensis And Its Medicinal Preparations by Capillary Electrophoresis with Electrochemical Detection, Journal of Chromatogr A., 1042, 203–209. CrossRef

Chan, SC., Chang, YS., Wang, JP., Chen, SC., and Kuo, SC., 1998, Three new flavonoids and antiallergic, anti-inflammatory constituents from the heartwood of Dalbergia odorifera, Planta Medica, 64, 153–158. CrossRef

Chipuk, J.E., Moldoveanu, T., Llambi, F., Parsons, M.J., and Green, D.R., 2010, The BCL-2 family reunion, Molecular cell, 37, 299–310. CrossRef

CLCbio, 2013, Molegro Virtual Docker User Manual, MVD 2013.6.0 for Windows, Linux, and Mac OS X, Molegro A CLC bio company. Link

Drwal, M.N., Banerjee, P., Dunkel, M., Wettig, M.R., and Preissner, R., 2014, ProTox: a web server for the insilico prediction of rodent oral toxicity, Nucleic Acids Research, 42(W1), W53–W58. CrossRef

Ebadi, A., Razzaghi-Aslc,N., Shahabipour, S., and Miri, R., 2014, Ab-Initio and Conformational Analysis of a Potent Vegfr-2 Inhibitor: A Case Study On Motesanib, Iranian Journal of Pharmaceutical Research, 13(2), 405-415. CrossRef

Ferrara, N., 2009, VEGF-A: a critical regulator of blood vessel growth, Eur. Cytokine Netw, 20(4), 158-163. Link

Hardjono, S., 2012, Modifikasi struktur 1-(benzoiloksi) urea dan hubungan kuantitatif struktur-aktivitas sitotoksiknya [modification of 1-(benzoyloxy)urea structure and the quantitative relationship between its structure and cytotoxic activities], Dissertation, [Surabaya]: Airlangga University.

Hinchliffe, A., 2008, Molecular Modeling for Beginners. 2nd ed., Chichester: John Wiley and Sons Ltd. Link

Hoi, P.M.,Li, S., Vong, C.T., Tseng, H.H.L., Kwan, Y.W., and Lee, S.M-Y., 2014, Recent Advances In Structure-Based Drug Design and Virtual Screening of Vegfr Tyrosine Kinase Inhibitors, Methods, 71, 85-91. CrossRef

Igney F.H. and Krammer P.H., 2002, Review: death and antideath: tumor resistance to apoptosis, Nat Rev Cancer, 2(4), 277-288. CrossRef

Jeltsch, M., Leppänen, V.M., Saharinen, P. and Alitalo K., 2013, Receptor tyrosine kinase-mediated angiogenesis, Cold Spring Harb Perspect Biol., 15(9), a009183. CrossRef

Kape, R., Parniske, M., Brandt, S., and Werner, D., 1992, Isoliquiritigenin, A Strong Nod Gene- and Glyceollin Resistance-inducing Flavonoid from Soybean Root Exudate, Appl Environ Microbiol, 58, 1705–1710. CrossRef

Kartasasmita, R.E., Herowati, R., and Gusdinar, T., 2010, Docking Study of Quercetin Derivatives on Inducible Nitric Oxide Synthase and Prediction of Their Absorption and Distribution Properties, Journal of Applied Sciences, 10(23), 3098-3104. CrossRef

Kennedy, R.K., Veena, V., Ravindra, P., Naik, Lakshmi, P., Krishna, R., Sudharani, S., and Sakthivel, N., 2015, Phenazine-1-carboxamide (PCN) from Pseudomonas sp. strain PUP6 selectively induced apoptosis in lung (A549) and breast (MDA MB-231) cancer cells by inhibition of antiapoptotic Bcl-2 family proteins, International Journal on Programmed Cell Death, 20(6), 858-868. CrossRef

Kinghorn, A.D., Drug discovery from natural products. In: Lemke, TL.; Williams, DA., Foye’s, 2008, Principles of Medicinal Chemistry. 6th Edition. Philadelphia, PA, USA: Wolters Kluwer/Williams & Wilkins.

Kumar, V., Cotran, R.S., and Robins, S., 2005, Basic Pathology 7th Ed. Penerbit Buku Kedokteran EGC. Jakarta.

Kusumaningrum, S., Budianto, E., Kosela, S., Sumaryono, W., and Juniarti, F., 2014, The molecular docking of 1,4-naphthoquinone derivatives as inhibitors of Polo-like kinase 1 using Molegro Virtual Docker, Journal of Applied Pharmaceutical Science, 4(11), 047-053. CrossRef

La, D.S., Belzile, J., Bready, J.V., Coxon, A., DeMelfi, T., Doerr, N., Estrada, J., Flynn, J.C., Flynn, S.R., Graceffa, R.F., Harriman, S.P., Larrow, J.F., Long, A.M., Martin, M.W., Morrison, M.J., Patel, V.F., Roveto, P.M., Wang, L., Weiss, M.M., Whittington, D.A., Teffera, Y., Zhao, Z., Polverino, A.J., and Harmange, J.C., 2008, Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis, Journal of Medicinal Chemistry, 51(6),1695-1705. CrossRef

Lipinski, C.A., Lombardo, F., Dominy, B.W. and Feeney, F.J., 1997, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Advanced Drug Delivery Reviews, 23, 3-25. CrossRef

Liu, Y.M., Ni, L.Q.,Wang, S.S., Lv, Q.L., Chen, W.J. and Ying, S.P., 2018, Outcome and prognostic factors in cervical cancer patients treated with surgery and concurrent chemoradiotherapy: a retrospective study, World Journal of Surgical Oncology, 16(18), 1-7. CrossRef

Martel, C.D., Plummer, M., Vignat, J. and Franceschi, S., 2017, Worldwide burden of cancer attributable to HPV by site, country and HPV type, International Journal of Cancer, 141, 664–670. CrossRef

Minggarwati, 2017, Uji Aktivitas Antikanker dan Identifikasi Senyawa Aktif dari Fraksi Umbi Bawang Sabrang (Eluetherine palmifolia (L.) Merr.) Terhadap, Sel Kanker Hela. [SKRIPSI]. Malang. Universitas Islam Negeri Maulana Malik Ibrahim Malang. Link

Pan, X., Kong, L., Zhang, Y., Cheng, C. and Tan, R., 2000, In Vitro Inhibition of Rat Monoamine Oxidase by Liquiritigenin and Isoliquiritigenin Isolated From Sinofranchetia Chinensis, Acta Pharmacol Sin. 21, 949–953. Link

Pires, D.E.V., Blundell, T.L. and Ascher, D.B., 2015, pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures, Journal of Medical Chemistry, 58, 4066-4072. CrossRef

Rastogi, R.P. and Sinha, R.P. 2009. Apoptosis: molecular mechanisms and pathogenicity, EXCLI Journal, 8, 155–181. Link

Siswandono, editor. 2016. Kimia medisinal I [Medicinal chemistry I]. 2nd edition. Surabaya, Airlangga University Press.

Sun, S., Hail Jr, N. and Lotan, R., 2004, Apoptosis as a novel target for cancer chemoprevention, Journal of the National Cancer Institute, 96(9), 662-272. CrossRef

Supandi, Yeni, Merdekawati F., 2018, In Silico Study of Pyrazolylaminoquinazoline Toxicity by Lazar, Protox, and Admet Predictor, Journal of Applied Pharmaceutical Science, 8(09), 119-129. CrossRef

Thomsen, R. and Christensen, M.H., 2006, MolDock: A New Technique for High-Accuracy Molecular Docking, Journal of Medical Chemistry, 49(11), 3315-3321. CrossRef


Copyright (c) 2019 Roihatul Mutiah, Muhammad Fawaz hariz, Yen Yen Ari Indrawijaya, Burhan Ma'arif

Indexed by:





Indonesian Society for Cancer Chemoprevention